Marea Therapeutics Appoints Ian Clements as Chief Financial Officer
View
Posts by Mat Knecht
How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease
View
Marea Therapeutics launches with $190M, seeing a ‘fixable problem’ in a neglected cardiometabolic target
View
Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases
View
Marea, Incubated by Third Rock, Gets $190M to Take Aim at Remnant Cholesterol
View